TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman

(NasdaqGM:TMDX), SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report by activist short-seller Scorpion Capital. TransMedics' stock price has dropped $9.84, or 13%, since Scorpion released a report, titled “Walk Like An […]

FFW Corporation and Crossroads Bank Welcome Stacy Wiley as Vice President and Chief Financial Officer

(PinkSheets:FFWC),(Pinksheets:FFWC), WABASH, Ind., Jan. 24, 2025 (GLOBE NEWSWIRE) — Stacy Wiley has been appointed Vice President and Chief Financial Officer at Crossroads Bank. Stacy brings extensive expertise, exceptional communication skills, and strong leadership to the team. With a Bachelor of Science and an MBA in Business Management from Purdue Fort Wayne, along with a tax

FTAI (FTAI) Faces Potential Delay in Filing Annual Report Amid Securities Class Action – Hagens Berman

(NASDAQ:FTAI), SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI), a prominent aviation leasing and financing company, is facing a potential delay in filing its annual report for 2024 after a critical report from a well-known short-seller prompted an internal review. The company's disclosure caused the price of FTAI shares to

BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman

(NASDAQ:BIOA), SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) — BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege the company misled investors about the safety and prospects of a key drug candidate before its initial public offering last September. Hagens Berman urges investors who

STELLA AI, Dealer Funnel, and Client Command Unite to Unveil AutoPilot at NADA – Revolutionizing Dealership Growth

In a groundbreaking partnership heading into NADA, STELLA Automotive AI, Dealer Funnel, and Client Command have joined forces to launch a revolutionary new offering: AutoPilot. Designed to empower automotive dealerships, AutoPilot integrates cutting-edge technologies to effortlessly deliver unparalleled sales and service growth by engaging active in-market shoppers. The AutoPilot solution has delivered impressive results during

E Split Corp. Class A Distribution

(TSX:ENS),(TSX:ENS.PR.A),(TSX:ENS-PA), TORONTO, Jan. 24, 2025 (GLOBE NEWSWIRE) — E Split Corp. (TSX: ENS) (the “Fund”) is pleased to announce that a distribution for January 2025 will be payable to Class A shareholders of E Split Corp. as follows: Record Date Payable Date Distribution Per Equity Share January 31, 2025 February 14, 2025 $0.13 The equity

Johnson & Johnson Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations – JNJ

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning possible violations of federal securities laws. J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance

Levi & Korsinsky Reminds Polestar Automotive Holding UK PLC Investors of the Ongoing Investigation into Potential Violations of Securities Laws – PSNY

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Polestar Automotive Holding UK PLC ("Polestar Automotive Holding UK PLC") (NASDAQ:PSNY) concerning possible violations of federal securities laws. On January 16, 2025, Polestar filed a report with the U.S. Securities and Exchange

Intellia Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Intellia Therapeutics, Inc. (NTLA)

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia Therapeutics, Inc. ("Intellia Therapeutics, Inc.") (NASDAQ:NTLA) concerning possible violations of federal securities laws. Intellia issued a press release on January 9, 2025, "announc[ing] its strategic priorities and key anticipated 2025 milestones".

Transocean Ltd. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights – RIG

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=124922&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top